Leatt Corporation - Form 10-Q - Filed by newsfilecorp.com

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10−Q

(Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: June 30, 2014

[_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to _____________

Commission File No. 000-54693

LEATT CORPORATION
(Exact name of registrant as specified in its charter)

Nevada 20-2819367
(State or other jurisdiction of incorporation or (I.R.S. Employer Identification No.)
organization)  

50 Kiepersol Drive, Atlas Gardens, Contermanskloof Road,
Durbanville, Western Cape, South Africa, 7441
(Address of principal executive offices)

+(27) 21-557-7257
(Registrant’s telephone number, including area code)

__________________________________________________________________
(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X]      No [_]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes [X]      No [_]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [_] Accelerated filer                   [_]
Non-accelerated filer   [_] (Do not check if a smaller reporting company) Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes [_]      No [X]


The number of shares outstanding of each of the issuer’s classes of common stock, as of August 11, 2014 is as follows:

Class of Securities Shares Outstanding
Common Stock, $0.001 par value 5,200,623



LEATT /CORPORATION
 
Quarterly Report on Form 10-Q
Three and Six Months Ended June 30, 2014

TABLE OF CONTENTS

PART I 2
FINANCIAL INFORMATION 2
ITEM 1. FINANCIAL STATEMENTS. 2
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. 8
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. 14
ITEM 4. CONTROLS AND PROCEDURES. 15
PART II 15
OTHER INFORMATION 15
ITEM 1. LEGAL PROCEEDINGS. 15
  ITEM 1A. RISK FACTORS. 16
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS. 16
ITEM 4. ITEM 3. DEFAULTS UPON SENIOR SECURITIES. 16
ITEM 4. MINE SAFETY DISCLOSURES. 16
ITEM 5. OTHER INFORMATION. 16
ITEM 6. EXHIBITS. 16

i


PART I
FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

LEATT CORPORATION
CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2014 AND 2013

  Page(s)
Financial Statements  
                                     Consolidated Balance Sheets 2
                                     Consolidated Statements of Operations and Comprehensive Loss 3
                                     Consolidated Statement of Changes in Stockholders' Equity 4
                                     Consolidated Statements of Cash Flows 5
                                     Notes to Consolidated Financial Statements 6 - 7

- 1 -


LEATT CORPORATION
CONSOLIDATED BALANCE SHEETS

  June 30 2014     December 31 2013  
    Unaudited     Audited  
             
ASSETS   
             
Current Assets            
             
 Cash and cash equivalents $  640,184   $  835,012  
 Short-term investments   58,142     58,130  
 Accounts receivable   2,272,757     3,139,273  
 Inventory   3,458,175     3,259,274  
 Payments in advance   479,454     144,302  
 Income tax refunds receivable   299     299  
 Deferred tax asset   110,000     110,000  
 Prepaid expenses and other current assets   611,004     1,092,450  
   Total current assets   7,630,015     8,638,740  
             
Property and equipment, net   844,039     891,728  
Other Assets            
   Other receivables   270,000     330,000  
   Deposits   17,264     19,469  
   Intangible assets   89,189     89,960  
     Total other assets   376,453     439,429  
Total Assets $  8,850,507   $  9,969,897  
             
LIABILITIES AND STOCKHOLDERS' EQUITY   
             
Current Liabilities            
 Accounts payable and accrued expenses $  1,824,556   $  2,076,809  
 Short-term loan, net of finance charges   325,883     833,735  
     Total current liabilities   2,150,439     2,910,544  
             
Deferred tax liabilities   40,633     40,680  
             
Commitments and contingencies            
             
Stockholders' Equity            
Preferred stock, $.001 par value, 1,120,000 shares authorized, 120,000 shares issued and outstanding   3,000     3,000  
Common stock, $.001 par value, 28,000,000 shares authorized, 5,200,623 shares issued and outstanding   130,008     130,008  
 Additional paid - in capital   7,309,942     7,307,515  
 Accumulated other comprehensive loss   (102,809 )   (111,864 )
 Accumulated deficit   (680,706 )   (309,986 )
     Total stockholders' equity   6,659,435     7,018,673  
Total Liabilities and Stockholders' Equity $  8,850,507   $  9,969,897  

See accompanying notes to consolidated financial statements
- 2 -


LEATT CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

   

Three Months Ended

 

 

Six Months Ended

 
   

June 30

 

 

June 30

 
   

2014

 

 

2013

 

 

2014

 

 

2013

 
   

Unaudited

 

 

Unaudited

 

 

Unaudited

 

 

Unaudited

 
                         
Revenues $  4,167,394   $  3,616,598   $  7,690,869   $  6,864,645  
                         
Cost of Revenues   1,858,390     1,830,720     3,486,164     3,483,754  
                         
Gross Profit   2,309,004     1,785,878     4,204,705     3,380,891  
                         
Product Royalty Income   50,448     142,224     71,263     179,686  
                         
Operating Expenses                        

Salaries and wages

  576,177     552,501     1,103,223     1,131,641  

Commissions and consulting expenses

  141,234     159,996     307,251     283,169  

Professional fees

  280,466     451,516     614,522     816,111  

Advertising and marketing

  389,659     403,688     675,053     730,325  

Office rent and expenses

  61,867     59,411     121,985     132,814  

Research and development costs

  333,035     276,747     614,327     565,605  

Bad debt expense

  223     -     22,295     -  

General and administrative expenses

  541,284     559,511     1,046,238     1,100,684  

Depreciation

  69,989     97,429     147,508     191,455  

Total operating expenses

  2,393,934     2,560,799     4,652,402     4,951,804  
                         
Loss from Operations   (34,482 )   (632,697 )   (376,434 )   (1,391,227 )
                         
Other Income (Expense)                        

Interest and other income (expense), net

  4,528     (2,647 )   5,594     1,142  

Total other income (expense)

                       
    4,528     (2,647 )   5,594     1,142  
Loss Before Income Taxes   (29,954 )   (635,344 )   (370,840 )   (1,390,085 )
                         
Income Taxes   (120 )   920     (120 )   920  
                         
Net Loss Available to Common Shareholders $  (29,834 ) $  (636,264 ) $  (370,720 ) $  (1,391,005 )
                         
Net Loss per Common Share                        

Basic

$  (0.01 ) $  (0.12 ) $  (0.07 ) $  (0.27 )

Diluted

$  (0.01 ) $  (0.12 ) $  (0.07 ) $  (0.27 )
                         
Weighted Average Number of Common Shares Outstanding                        

Basic

  5,200,623     5,200,623     5,200,623     5,200,623  

Diluted

  5,200,623     5,200,623     5,200,623     5,200,623  
                         
Comprehensive Loss                        

Net Loss

$  (29,834 ) $  (636,264 ) $  (370,720 ) $  (1,391,005 )

Other comprehensive loss, net of $-0- deferred income taxes in 2014 and 2013

                       

Foreign currency translation

  3,884     (101,109 )   9,055     (216,534 )
                         

Total Comprehensive Loss

$  (25,950 ) $  (737,373 ) $  (361,665 ) $  (1,607,539 )

See accompanying notes to consolidated financial statements
- 3 -


LEATT CORPORATION
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
AS OF AND FOR THE SIX MONTHS ENDED JUNE 30, 2014

                                  Accumulated              
                                  Other              

 

  Preferred Stock A     Common Stock     Additional     Comprehensive     Accumulated        

 

                          Paid - In                    

 

  Shares     Amount     Shares     Amount     Capital     Income (Loss)     Deficit     Total  

 

                                               

 

                                               

Balance, January 1, 2014

  120,000   $  3,000     5,200,623   $  130,008   $ 7,307,515   $  (111,864 ) $  (309,986 ) $  7,018,673  

 

                                               

Compensation cost recognized in connection with stock options

  -     -     -     -     2,427     -     -     2,427  

                               

Net loss

  -     -     -     -     -     -     (370,720 )   (370,720 )

 

                                               

Foreign currency translation adjustment

  -     -     -     -     -     9,055     -     9,055  

                               

Balance, June 30, 2014

  120,000   $  3,000     5,200,623   $  130,008   $  7,309,942   $  (102,809 ) $  (680,706 ) $  6,659,435  

See accompanying notes to consolidated financial statements

- 4 -


LEATT CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2014 AND 2013

    2014     2013  
Cash flows from operating activities            
 Net loss $  (370,720 ) $  (1,391,005 )
 Adjustments to reconcile net loss to net cash provided by operating activities:            
     Depreciation   147,508     191,455  
     Deferred income taxes   (47 )   (971 )
     Stock-based compensation   2,427     -  
     Inventory reserve   165,165     -  
     Gain on sale of property and equipment   (3,938 )   366  
   (Increase) decrease in:            
       Accounts receivable   866,516     734,333  
       Inventory   (364,066 )   465,887  
       Payments in advance   (335,152 )   48,131  
       Prepaid expenses and other current assets   481,446     521,152  
       Other receivables   60,000     -  
       Deposits   2,205     2,873  
   Increase (decrease) in:            
       Accounts payable and accrued expenses   (252,253 )   62,247  
       Income taxes payable   -     (1,499 )
           Net cash provided by operating activities   399,091     632,969  
             
Cash flows from investing activities            
   Capital expenditures   (19,250 )   (51,316 )
   Proceeds from sale of property and equipment   6,699     2,844  
   Increase in short-term investments, net   (12 )   (232 )
           Net cash used in investing activities   (12,563 )   (48,704 )
             
Cash flows from financing activities            
 Repayments of short-term loan, net   (507,852 )   (529,813 )
           Net cash used in financing activities   (507,852 )   (529,813 )
             
Effect of exchange rates on cash and cash equivalents   (73,504 )   (90,703 )
             
Net decrease in cash and cash equivalents   (194,828 )   (36,251 )
             
Cash and cash equivalents - beginning   835,012     667,671  
             
Cash and cash equivalents - ending $  640,184   $  631,420  
             
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:            
Cash paid for interest $  11,495   $  7,994  
Cash paid for income taxes $  -   $  2,419  
             
Other noncash investing and financing activities            
Common stock issued for services $  2,427   $  -  

See accompanying notes to consolidated financial statements
- 5 -


LEATT CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Note 1 - Basis of presentation

The consolidated balance sheet as of December 31, 2013 was audited and appears in the Form 10-K filed by the Company with the Securities and Exchange Commission on March 19, 2014. The consolidated balance sheet as of June 30, 2014 and the consolidated statements of operations and comprehensive loss for the three months and six months ended June 30, 2014 and 2013, changes in stockholders’ equity for the six months ended June 30, 2014, cash flows for the six months ended June 30, 2014 and 2013, and the related information contained in these notes have been prepared by management without audit. In the opinion of management, all adjustments (which include only normal recurring items) necessary to present fairly the financial position, results of operations and cash flows in conformity with generally accepted accounting principles as of June 30, 2014 and for all periods presented have been made. Interim operating results are not necessarily indicative of operating results for a full year.

Certain information and note disclosures normally included in the Company’s annual financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted. While management of the Company believes that the disclosures presented are adequate to make the information not misleading, it is suggested that these condensed consolidated financial statements be read in conjunction with the audited financial statements and notes thereto for the year ended December 31, 2013 as filed with the Securities and Exchange Commission in the Company’s Form 10-K.

Note 2 - Inventory

Inventory is stated at the lower of cost or market. Cost is determined using the first-in first-out (FIFO) method. Inventory consists primarily of finished goods. Shipping and handling costs are included in the cost of inventory. In assessing the inventory value, the Company must make estimates and judgments regarding reserves required for product obsolescence, aging of inventory and other issues potentially affecting the saleable condition of products. In performing such evaluations, the Company utilizes historical experience as well as current market information. The reserve for obsolescence for the six months ended June 30, 2014 and 2013 was $296,820 and $0, respectively.

Note 3 - Intangible Assets

The Company’s intangible assets consist of acquired patents with an indefinite useful life and are thus not amortized. Intangible assets are carried at cost less impairment. Amortization expense for the six months ended June 30, 2014 was zero. There was no impairment of intangible assets at June 30, 2014.

Note 4 - Short-term Loan

The Company carries two product liability insurance policies, one with a U.S. insurance carrier and a second with a South African insurance carrier. The Company finances payment of its short-term insurance premiums over the period of coverage, which is generally twelve months. The US short-term loan is payable in monthly installments of $91,014 over an 11 month period at an APR of 2.647% and the South African short-term loan is payable in monthly installments of $1,839 over a 10 month period at a flat interest rate of 3.50%.

The Company carries directors and officers liability insurance. The Company finances payment of its short-term insurance premiums over the period of coverage, which is generally twelve months. The short-term loan is payable in eleven payments of $4,997, at a 2.647% annual interest rate.

Note 5- Income Taxes

The Company uses the asset and liability approach to account for income taxes. Deferred tax assets and liabilities are determined based on the differences between the financial statement carrying amounts and the income tax basis of assets and liabilities. A valuation allowance is applied against any net deferred tax asset if, based on available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The provision for income taxes included taxes currently payable, if any, plus the net change during the period in deferred tax assets and liabilities recorded by the Company.

The Company applies the provisions of FASB ASC Topic 740-10, Accounting for Uncertainty in Income Taxes (“Standard”), which provides that the tax effects from an uncertain tax position can be recognized in the consolidated financial statements only if the position is more likely than not of being sustained upon an examination by tax authorities. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, the standard provides guidance on derecognition, classification, interest and penalties; accounting in interim periods, disclosure and transition, and any amounts when incurred would be recorded under these provisions.

- 6 -


The Company’s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. As of June 30, 2014, the Company has no unrecognized tax benefits. The Company’s 2011 income tax return is under examination by the Internal Revenue Service.

Note 6 - Net Income Per Share of Common Stock

Basic net income per common share is computed using the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted–average number of common stock shares and dilutive potential common shares outstanding during the period. For the three months and six months ended June 30, 2014, the Company had 328,000 potential common shares, consisting of 120,000 preferred shares and 208,000 stock options, outstanding that were anti-dilutive and therefore not included in diluted net income per share.

Note 7 - Litigation

In the ordinary course of business, the Company is involved in various legal proceedings involving product liability and personal injury and intellectual property litigation. The Company is insured against loss for certain of these matters. The Company will record contingent liabilities resulting from asserted and unasserted claims against it when it is probable that the liability has been incurred and the amount of the loss is reasonably estimable. The Company will disclose contingent liabilities when there is a reasonable possibility that the ultimate loss will exceed the recorded liability. While the outcome of currently pending litigation is not yet determinable, the ultimate exposure with respect to these matters cannot be ascertained. However, based on the information currently available to the Company, the Company does not expect that any liabilities or costs that might be incurred to resolve these matters will have a material adverse effect on the financial condition, results of operations, liquidity or cash flows of the Company.

Note 8 – Subsequent Events

The company has evaluated all subsequent events through the date the financial statements were released.

- 7 -


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Special Note Regarding Forward Looking Statements

This report contains forward-looking statements that are contained principally in the sections entitled “Our Business,” “Risk Factors,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to, the factors described in the section captioned “Risk Factors” in our latest annual report on Form 10-K filed with the SEC. In some cases, you can identify forward-looking statements by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “would” and similar expressions intended to identify forward-looking statements. Forward-looking statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements include, among other things, statements relating to:

Also, forward-looking statements represent our estimates and assumptions only as of the date of this quarterly report. You should read this quarterly report and the documents that we reference and filed as exhibits to the quarterly report completely and with the understanding that our actual future results may be materially different from what we expect. Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in any forward-looking statements, even if new information becomes available in the future.

Use of Certain Defined Terms

Except as otherwise indicated by the context, references in this quarterly report to:

- 8 -


Overview

Leatt designs, develops, markets and distributes personal protective equipment for participants in all forms of motor sports and leisure activities, including riders of motorcycles, bicycles, snowmobiles and ATVs, as well as racing car drivers. The Company sells its products to customers worldwide through a global network of distributors and retailers. Leatt also acts as the original equipment manufacturer for neck braces sold by other international brands.

The Company’s flagship products are based on the Leatt-Brace® system, a patented injection molded neck protection system owned by Xceed Holdings, designed to prevent potentially devastating injuries to the cervical spine and neck. The Company has the exclusive global manufacturing, distribution, sale and use rights to the Leatt-Brace®, pursuant to a license agreement between the Company and Xceed Holdings, a company owned and controlled by the Company’s Chairman and founder, Dr. Christopher Leatt. The Company also has the right to use apparatus embodying, employing and containing the Leatt-Brace® technology and has designed, developed, marketed and distributed other personal protective equipment using this technology, as well as its own developed technology, including the Company’s new body protection products which it markets under the Leatt Protection Range brand.

The Company’s research and development efforts are conducted at its research facilities, located at its executive headquarters in Cape Town, South Africa. The Company employs 5 full-time employees who are dedicated exclusively to research, development, and testing. The Company also utilizes consultants, academic institutions and engineering companies as independent contractors or consultants, from time to time, to assist it with its research and development efforts. Leatt products have been tested and reviewed internally and by external bodies. All Leatt products are compliant with applicable European Union directives, or CE certified, where appropriate. Certain products, such as the Moto R, have been certified by SFI Foundation (USA) and the Moto GPX was tested by BMW Motorrad (Germany) and reviewed by KTM (Austria). The Company is also in discussions with governing and racing bodies, such as the Fédération Internationale de l'Automobile (FIA), the Fédération Internationale de Motocyclisme (FIM) and the National Association for Stock Car Auto Racing (NASCAR), to have the Leatt-Brace® accredited by these bodies.

Our products are manufactured in China under outsource manufacturing arrangements with third-party manufacturers located there. The Company utilizes outside consultants and its own employees to ensure the quality of its products through regular on-site product inspections. Products purchased through international sales are usually shipped directly from our manufacturers’ warehouses or points of dispatch to customers or their import agents.

Leatt earns revenues through the sale of its products through approximately 60 distributors worldwide, who in turn sell its products to retailers. Leatt distributors are required to follow certain standard business terms and guidelines for the sale and distribution of Leatt products. Two Eleven and Leatt SA directly distribute Leatt products to retailers in the United States and South Africa, respectively.

Principal Factors Affecting Our Financial Performance

We believe that the following factors will continue to affect our financial performance:

- 9 -


Results of Operations

The following summary of our results of operations should be read in conjunction with our financial statements and the notes thereto for the three-month and six-month periods ended June 30, 2014 and 2013 included herein. The following tables set forth key components of our results of operations for the periods indicated, both in dollars and as a percentage of sales revenue and key components of our revenue for the periods indicated in dollars and percentages.

Three Months Ended June 30, 2014 compared to the Three Months Ended June 30, 2013

The following table summarizes the results of our operations during the three-month periods ended June 30, 2014 and 2013 and provides information regarding the dollar and percentage increase or (decrease) in such periods:

- 10 -



  Three Months Ended June 30,           Percentage  
  2014     2013     $Increase     Increase  
Item                (Decrease)     (Decrease)  
                   
REVENUES $ 4,167,394   $  3,616,598   $  550,796     15%  
COST OF REVENUES   1,858,390     1,830,720   $  27,670     2%  
GROSS PROFIT   2,309,004     1,785,878   $  523,126     29%  
PRODUCT ROYALTY INCOME   50,448     142,224   $  (91,776 )   -65%  
OPERATING EXPENSES             $          
   Salaries and Wages   576,177     552,501   $  23,676     4%  
   Commissions and Consulting   141,234     159,996   $  (18,762 )   -12%  
   Professional Fees   280,466     451,516   $  (171,050 )   -38%  
   Advertising and Marketing   389,659     403,688   $  (14,029 )   -3%  
   Office Rent and Expenses   61,867     59,411   $  2,456     4%  
   Research and Development Costs   333,035     276,747   $  56,288     20%  
   Bad debt expense   223     -   $  223     100%  
   General and Administrative   541,284     559,511   $  (18,227 )   -3%  
   Depreciation   69,989     97,429   $  (27,440 )   -28%  
Total Operating Expenses   2,393,934     2,560,799   $  (166,865 )   -7%  
LOSS FROM OPERATIONS   (34,482 )   (632,697 ) $  598,215     95%  
   Other Income (Expense)   4,528     (2,647 ) $  7,175     271%  
LOSS BEFORE INCOME TAXES   (29,954 )   (635,344 ) $  605,390     95%  
     Income Taxes   (120 )   920   $  (1,040 )   -113%  
NET LOSS $  (29,834 ) $  (636,264 ) $  606,430     95%  

Revenues – We earn revenues from the sale of our protective gear comprising of neck braces, body armor and other products, parts and accessories both in the United States and internationally. For the three months ended June 30, 2014 and 2013, revenues associated with international customers were $2.36 million and $2.23 million, or 57% and 62% of revenues, respectively. Revenues for the three months ended June 30, 2014 were $4.17 million, a 15% increase, compared to revenues of $3.62 million for the quarter ended June 30, 2013. This increase in revenues is attributable to a $0.80 million increase in neck brace sales, which was partially offset by a $0.26 million decrease in body armor sales during the period ended June 30, 2014.

The following table sets forth our revenues by product line for the three months ended June 30, 2014 and 2013:

  Three Months Ended June 30,  
  2014     %of     2013     %of  
        Revenues           Revenues  
Neck Braces $ 2,559,562     61%   $  1,763,513     49%  
Body Armor   1,399,785     34%     1,655,351     46%  
Other Products, Parts and Accessories   208,047     5%     197,734     5%  
$ 4,167,394     100%   $  3,616,598     100%  

Sales of our flagship Neck Brace accounted for $2.56 million and $1.76 million, or 61% and 49% of our revenues for the quarters ending June 30, 2014 and 2013, respectively. The 45% increase in Neck Brace revenues is primarily as a result of the successful market acceptance of the Fusion 2.0 Junior and 5.5 Neck Brace both in the United States and abroad.

Our Body Armor products are comprised of chest protectors, full upper body protectors, upper body protection vests, back protectors, knee braces, and knee and elbow guards. Body Armor sales accounted for $1.4 million and $1.66 million, or 34% and 46% of our revenues for the quarters ending June 30, 2014 and 2013, respectively. The 15% decrease in Body Armor revenues was primarily due to a decrease in the volume of Body Armor units sold to our international distributors during the period.

- 11 -


Our Other Products, Parts and Accessories are comprised of aftermarket support items required primarily to replace worn or damaged parts through our global distribution network, as well as clothing, outerwear and accessories that include hats, jackets, bags, hydration kits and cooling garments. Other Products, Parts and Accessories sales accounted for $0.21 million and $0.20 million, or 5% and 5% of our revenues for the quarters ending June 30, 2014 and 2013, respectively. The increase in our Other Products, Parts and Accessories is primarily due to marginally higher sales of hydration kits during the period.

Cost of Revenues and Gross Profit – Cost of revenues for the quarters ended June 30, 2014 and 2013 were $1.86 million and $1.83 million, respectively. Gross Profit for the quarters ended June 30, 2014 and 2013 were $2.31 million and $1.79 million, respectively, or 55% and 49% of revenues respectively. The increase in gross profit margin was primarily due to increased Neck Brace sales in the United States and internationally. Our flagship Neck Brace product range continues to generate a higher gross margin than Body Armor products and they represent 61% of the total Company sales in the second quarter of 2014, as compared to 49% in the second quarter of 2013.

Product Royalty Income – Product royalty income is earned on sales to distributors that have royalty agreements in place, as well as sales of licensed products by third parties that have licensing agreements in place. Product royalty income for the three months ended June 30, 2014 and 2013 were $50,448 and $142,224, respectively. The 65% decrease in product royalty income is due to decreased revenues from sales of licensed products by licensees.

Salaries and Wages – Salaries and wages for the quarters ended June 30, 2014 and 2013 were $576,177 and $552,501, respectively. This 4% increase in salaries and wages is primarily due to the employment of additional US sales management staff, as well as the restructuring of US sales staff remuneration packages.

Commissions and Consulting Expense – During the quarters ended June 30, 2014 and 2013, commissions and consulting expenses were $141,234 and $159,996, respectively. This 12% decrease in commissions and consulting expenses is primarily due to the restructuring of US sales staff remuneration packages.

Professional Fees – Professional fees consist of costs incurred for audit, tax and regulatory filings, as well as patent protection, product liability litigation expenses incurred as the Company continues to expand. Professional fees for the quarters ended June 30, 2014 and 2013 were $280,466 and $451,516, respectively. This 38% decrease in professional fees is primarily due to decreased spending on patent litigation during the 2014 period. The Company settled various patent infringement lawsuits during the year ended December 31, 2013.

Advertising and Marketing – The Company places paid advertising in various motorsport magazines and online media, and we sponsor a number of events, teams and individuals to increase product and brand visibility. Advertising and marketing expenses for the quarters ended June 30, 2014 and 2013 were $389,659 and $403,688, respectively. The 3% decrease in advertising and marketing expenditures during the 2014 period is primarily due to the Company’s continued focus on online marketing campaigns that are more cost effective and reach a wider audience than the more traditional print based campaigns.

Office Rent and Expenses – Office rent and expenses for the quarters ended June 30, 2014 and 2013 were $61,867 and $59,411, respectively. The 4% increase in office rent and expenses is primarily the result of the annual rental escalation for our Two Eleven facilities.

Research and Development Costs – Research and development costs consist of the salaries of staff members that are directly involved in the research and development of innovative products, as well as the direct costs associated with developing these products. Research and development costs for the quarter ended June 30, 2014, increased to $333,035, from $276,747 during the same 2013 quarter. The 20% increase in research and development costs is a result of costs incurred to develop the Company’s widening range of innovative products.

Bad Debt Expense Bad debt expense for the quarters ended June 30, 2014 and 2013 were $223 and $0, respectively. This marginal increase in Bad Debt Expense is due to the write off of an immaterial unrecoverable debt.

General and Administrative Expenses – General and administrative expenses consist of insurance, travel, merchant fees, telephone, office and computer supplies. General and administrative expenses for the quarters ended June 30, 2014 and 2013 were $541,284 and $559,511, respectively. The 3% decrease in general and administrative expenses is primarily as a result of decreased spending on international travel during the 2014 period, that was partially setoff by increased spending on courier and postage as a result of the research and development activities referred to above.

- 12 -


Depreciation Expense – Depreciation expense for the quarters ended June 30, 2014 and 2013 were $69,989 and $97,429, respectively. This 28% decrease in depreciation is primarily as a result of various assets being fully depreciated during the period as they had reached the end of their economic useful lives.

Total Operating Expenses – Total operating expenses decreased by $166,865 to $2,393,934 in the three months ended June 30, 2014, or 7%, compared to $2,560,799 in the 2013 period. This decrease is primarily due to decreased spending on professional fees relating to patent litigation, that were partially offset by increased spending on the research and development costs discussed above.

Net loss – The net loss after income taxes for the quarter ended June 30, 2014 was $29,834, as opposed to net loss after income taxes of $636,264 for the quarter ended June 30, 2013. This decrease in net loss is primarily due to increased revenues and decreased cost of revenues and operating costs discussed above.

Six Months Ended June 30, 2014 compared to the Six Months Ended June 30, 2013

The following table summarizes the results of our operations during the six-month periods ended June 30, 2014 and 2013 and provides information regarding the dollar and percentage increase or (decrease) in such periods:

  Six Months Ended June 30,                           Percentage  
  2014     2013     $ Increase     Increase  
Item                                     (Decrease)     (Decrease)  
                       
REVENUES $  7,690,869   $  6,864,645   $  826,224     12%  
COST OF REVENUES   3,486,164     3,483,754   $  2,410     0%  
GROSS PROFIT   4,204,705     3,380,891   $  823,814     24%  
PRODUCT ROYALTY INCOME   71,263     179,686   $  (108,423 )   -60%  
OPERATING EXPENSES             $          
   Salaries and Wages   1,103,223     1,131,641   $  (28,418 )   -3%  
   Commissions and Consulting   307,251     283,169   $  24,082     9%  
   Professional Fees   614,522     816,111   $  (201,589 )   -25%  
   Advertising and Marketing   675,053     730,325   $  (55,272 )   -8%  
   Office Rent and Expenses   121,985     132,814   $  (10,829 )   -8%  
   Research and Development Costs   614,327     565,605   $  48,722     9%  
   Bad debt expense   22,295     -   $  22,295     100%  
   General and Administrative   1,046,238     1,100,684   $  (54,446 )   -5%  
   Depreciation   147,508     191,455   $  (43,947 )   -23%  
Total Operating Expenses   4,652,402     4,951,804   $  (299,402 )   -6%  
LOSS FROM OPERATIONS   (376,434 )   (1,391,227 ) $  1,014,793     73%  
   Other Income   5,594     1,142   $  4,452     390%  
LOSS BEFORE INCOME TAXES   (370,840 )   (1,390,085 ) $  1,019,245     73%  
   Income Taxes   (120 )   920   $  (1,040 )   -113%  
NET LOSS $  (370,720 ) $  (1,391,005 ) $  1,020,285     73%  

Revenues – For the six months ended June 30, 2014 and 2013, revenues associated with international customers were $ 4.33 million and $3.98 million, or 56% and 58% of revenues, respectively. Revenues for the six months ended June 30, 2014 were $7.69 million, a 12% increase, compared to revenues of $6.86 million for the six-month period ended June 30, 2013. This increase in revenues is attributable to a $0.92 million increase in neck brace sales, which was partially offset by a $0.09 million decrease in body armor sales during the period ended June 30, 2014.

The following table sets forth our revenues by product line for the six months ended June 30, 2014 and 2013:

- 13 -



  Six Months Ended June 30,  
  2014     % of     2013     % of  
        Revenues           Revenues  
Neck Braces $ 4,504,554     59%   $  3,580,887     52%  
Body Armor   2,790,636     36%     2,886,621     42%  
Other Products, Parts and Accessories   395,679     5%     397,137     6%  
$ 7,690,869     100%   $  6,864,645     100%  

Sales of our flagship Neck Brace accounted for $4.50 million and $3.58 million, or 59% and 52% of our revenues for the six-month period ended June 30, 2014 and 2013, respectively. The 26% increase in Neck Brace revenues is primarily as a result of the successful market acceptance of the Fusion 2.0 Junior and 5.5 Neck Brace in both the United States and abroad. Additionally, Neck Brace revenues increased in the 2014 period due to sales of new brace products at full value as compared to sales of older brace products at reduced close out prices in the prior year period.

Body Armor sales accounted for $2.79 million and $2.89 million, or 36% and 42% of our revenues for the six-month period ended June 30, 2014 and 2013, respectively. The 3% decrease in Body Armor revenues was primarily due to a decrease in the volume of body armor units sold to our international distributors during the period.

Other Products, Parts and Accessories sales remained stable at $395,679 or 5% of revenues for the six-month period ended June 30, 2014, as compared to $397,137, or 6% of our revenues during the same 2013 period.

Cost of Revenues and Gross Profit – Cost of revenues for the six-month period ended June 30, 2014 and 2013 were $3.49 million and $3.48 million, respectively. Gross Profit for the six-month period ended June 30, 2014 and 2013 were $4.20 million and $3.38 million, respectively, or 55% and 49% of revenues respectively. The increase in gross profit margin was primarily due to increased Neck Brace sales in the United States and abroad. The Company’s flagship Neck Brace product range continues to generate a higher gross margin than Body Armor products and they represent 59% of the total Company sales for the six-month period ended June 30, 2014, as compared to 52% for the six-month period ended June 30, 2013. Additionally, Neck Brace margins improved in the United States due to a decrease in the close out of older inventory as compared to the prior year period.

Product Royalty Income – Product royalty income for the six months ended June 30, 2014 and 2013 were $71,263 and $179,686, respectively. The 60% decrease in product royalty income is due to decreased revenues from sales of licensed products by licensees during the 2014 period.

Salaries and Wages – Salaries and wages for the six-month period ended June 30, 2014 and 2013 were $1,103,223 and $1,131,641, respectively. This 3% decrease in salaries and wages is primarily due to the streamlining of the Company’s US operational and selling activities during the 2014 period.

Commissions and Consulting Expense – During the six-month period ended June 30, 2014 and 2013, commissions and consulting expenses were $307,251 and $283,169, respectively. This 9% increase in commissions and consulting expenses is primarily due to increased commission paid to the Company’s European commissioned sales staff during the 2014 period.

Professional Fees – Professional fees for the six-month period ended June 30, 2014 and 2013 were $614,522 and $816,111, respectively. This 25% decrease in professional fees is primarily due to decreased spending on patent maintenance and litigation during the 2014 period. The Company settled various patent infringement lawsuits during the year ended December 31, 2013. Additionally, significant patent costs were incurred during the first quarter of 2013 as part of our application for additional patents which have since been fully filed or granted.

Advertising and Marketing – Advertising and marketing expenses for the six-month period ended June 30, 2014 and 2013 were $675,053 and $730,325, respectively. The 8% decrease in advertising and marketing expenditures during the 2014 period is primarily due to the Company’s continued focus on online and digital based marketing campaigns that are designed to be more cost effective and wider reaching than print advertising campaigns.

Office Rent and Expenses – Office rent and expenses for the six-month period ended June 30, 2014 and 2013 were $121,985 and $132,814, respectively. The 8% decrease in office rent and expenses during the 2014 period is primarily the result of the consolidation of additional warehouse space that was previously occupied by Two Eleven.

- 14 -


Research and Development Costs – These costs consists of the salaries of staff members that are directly involved in the research and development of innovative products, as well as the direct costs associated with developing these products. Research and development costs for the six-month period ended June 30, 2014 and 2013, increased to $614,327 from $565,605, respectively. This 9% increase in research and development costs during the 2014 period is a result of direct costs incurred to develop the Company’s widening range of innovative products.

Bad Debt Expense Bad debt expense for the six-month period ended June 30, 2014 and 2013 were $22,295 and $0, respectively. This 100% increase in bad debt expense during the 2014 period relates primarily to the write off of a debt owing by a US customer that went out of business.

General and Administrative Expenses – General and administrative expenses for the six-month period ended June 30, 2014 and 2013 were $1,046,238 and $1,100,684, respectively. The 5% decrease in general and administrative expenses during the 2014 period is primarily as a result of decreased expenditure on communication and international travel costs.

Depreciation Expense Depreciation expense for the six-month period ended June 30, 2014 and 2013 were $147,508 and $191,455, respectively. This 23% decrease in depreciation expense during the 2014 period is primarily as a result of various assets being fully depreciated during the period as they had reached the end of their economic useful lives.

Total Operating Expenses – Total operating expenses decreased by $299,402 to $4,652,402 in the six months ended June 30, 2014, or 6%, compared to $4,951,804 in the 2013 period. This decrease is primarily due to decreased professional fees relating to patent litigation and maintenance during the 2014 period discussed above.

Net loss –The net loss after income taxes for the six-month period ended June 30, 2014 was $370,720, as opposed to the net loss after income taxes of $1,391,005 for the six-month period ended June 30, 2013. This decrease in net loss is primarily due to increased revenues and decreased cost of revenues and operating costs discussed above.

Liquidity and Capital Resources

At June 30, 2014, we had cash and cash equivalents of $0.6 million and $0.05 million of short-term investments. The following table sets forth a summary of our cash flows for the periods indicated:

  June 30,  
  2014     2013  
Net cash provided by operating activities $  399,091   $  632,969  
Net cash used in investing activities $  (12,563 ) $  (48,704 )
Net cash used in financing activities $  (507,852 ) $  (529,813 )
Effect of exchange rate changes on cash and cash equivalents $  (73,504 ) $  (90,703 )
Net (decrease) in cash and cash equivalents $  (194,828 ) $  (36,251 )
Cash and cash equivalents at the beginning of period $  835,012   $  667,671  
Cash and cash equivalents at the end of period $  640,184   $  631,420  

Cash decreased by $194,828, or 23%, for the six months ended June 30, 2014. The primary sources of cash for the six months ended June 30, 2014 were decreased accounts receivables of $866,516 and decreased prepaid expenses and other assets of $481,446. The primary uses of cash for the six months ended June 30, 2014 was a net loss of $370,720, increased inventories of $364,066, increased payments in advance of $335,152 relating primarily to deposits paid for molds under development, and the repayment of a short-term loan of $507,852. As of June 30, 2014, we did not have any credit facilities or significant amounts owed to third party lenders.

The Company is currently meeting its working capital needs through cash on hand, as well as internally generated cash from operations. Management believes that its current cash and cash equivalent balances, along with the net cash generated by operations are sufficient to meet its anticipated operating cash requirements for at least the next twelve months. There are currently no plans for any major capital expenditures in the next twelve months. Our long-term financing requirements depend on our growth strategy, which relates primarily to our desire to increase revenue both domestically as well as internationally.

- 15 -


Obligations under Material Contracts

Pursuant to our Licensing Agreement with Xceed Holdings, we pay Xceed Holdings 4% of all neck brace sales revenue billed and received by the Company, on a quarterly basis based on sales of the previous quarter. In addition, pursuant to a separate license agreement between the Company and Mr. De Villiers, the Company is obligated to pay a royalty fee of 1% of all our billed and received neck brace sales revenue, in quarterly installments, based on sales of the previous quarter, to a trust that is beneficially owned and controlled by Mr. De Villiers.

Pursuant to a Premium Finance Agreement, dated October 11, 2013, between the Company and AFCO Acceptance Corporation “AFCO,” the company is obligated to pay AFCO an aggregate sum of $1,001,151 in eleven payments of $91,014, at a 2.647% annual interest rate, commencing on November 1, 2013 and ending on September 1, 2014. Any late payment during the term of the agreement will be assessed a late penalty of 5% of the payment amount due, and in the event of default AFCO has the right to accelerate the payment due under the agreement. As of June 30, 2014, the Company had not defaulted on its payment obligations under this agreement.

Pursuant to a Premium Finance Agreement, dated June 9, 2014, between the Company and AFCO Acceptance Corporation “AFCO,” the company is obligated to pay AFCO an aggregate sum of $59,244 in eleven payments of $4,997 at a 2.647% annual interest rate, commencing on June 1, 2014 and ending on April 1, 2015. Any late payment during the term of the agreement will be assessed a late penalty of 5% of the payment amount due, and in the event of default AFCO has the right to accelerate the payment due under the agreement. As of June 30, 2014, the Company had not defaulted on its payment obligations under this agreement.

Critical Accounting Policies and Estimates

Our discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported revenues and expenses during the reporting period.

There have been no material changes in our critical accounting policies or critical accounting estimates since December 31, 2013. We have not adopted any accounting policies since December 31, 2013 that have or will have a material impact on our consolidated financial statements. For further discussion of our accounting policies see the “Summary of Significant Accounting Policies” in the Notes to Consolidated Financial Statements, as of and for the year ended December 31, 2013 included in our annual report on Form 10-K filed for the period, as well as the notes in this Form 10-Q.

We have identified the following as the items that require the most significant judgment and often involve complex estimation: revenue recognition, estimating allowances for doubtful accounts receivable, inventory valuation, impairment of long-lived assets and accounting for income taxes.

Revenue and Cost Recognition - All manufacturing of Leatt products is performed by third party subcontractors in China. The Company's products are sold worldwide to a global network of distributors and dealers, and directly to consumers when there are no dealers or distributors in their geographic area (collectively the "customers"). Revenues from product sales are recognized when earned, net of applicable provisions for discounts and returns and allowances in the event of product defect. Revenue is considered to be realized or realizable and earned when all of the following criteria are met: title and risk of loss have passed to the customer, persuasive evidence of an arrangement exists, delivery has occurred, the price is fixed and determinable and collectability is reasonably assured. Our distributor payment terms range from pre-payment in full to 60 days after shipment and subsequent sales of our products by distributors have no effect on the amount and timing of payments due to us. Furthermore, products purchased by distributors may not be returned to us in the event that any such distributor relationship is terminated.

Since the Company (through its wholly owned subsidiary) serves as the distributor of Leatt products in the United States, the Company records its revenue and related cost of revenue for its product sales in the United States upon shipment of the merchandise to the dealer or to the ultimate consumer when there is no dealer in the geographic area and the sales order was received directly from, and paid by, the ultimate consumer. Since the Company (through its South African branch) serves as the distributor of Leatt products in South Africa, the Company records its revenue and related cost of revenue for its product sales in South Africa upon shipment of the merchandise from the branch to the dealer. International sales (other than in South Africa) are generally drop-shipped directly from the third party manufacturer to the international distributors.

- 16 -


Revenue and related cost of revenue is recognized at the time of shipment from the manufacturer's port when the shipping terms are Free On Board ("FOB") shipping point, Cost and Freight ("CFR") or Cost and Insurance to named place ("CIP") as legal title and risk of loss to the product pass to the distributor. Sales to all customers (distributors, dealers and consumers) are generally final; however, in limited instances, product may be returned due to product quality issues. Historically, returns due to product quality issues have not been material and there have been no distributor terminations that resulted in product returns. Cost of revenues also includes royalty fees associated with sales of Leatt-Brace products.

Product royalty income is recorded as the underlying product sales occur, in accordance with the related licensing arrangements.

Allowance for Doubtful Accounts Receivable - Accounts receivable consist of amounts due to the Company from normal business activities. Credit is granted to substantially all distributors on an unsecured basis. We continuously monitor collections and payments from customers and maintain an allowance for doubtful accounts receivable based upon historical experience and any specific customer collection issues that have been identified. In determining the amount of the allowance, we are required to make certain estimates and assumptions. Accounts receivable balances that are still outstanding after we have used reasonable collection efforts are written off as uncollectible. While such credit losses have historically been minimal, within our expectations and the provisions established, we cannot guarantee that we will continue to experience the same credit loss rates that we have in the past. A significant change in the liquidity or financial position of any of our significant customers could have a material adverse effect on the collectability of our accounts receivable and our future operating results.

Inventory Valuation – Inventory is stated at the lower of cost or market. Cost is determined using the first-in first-out (FIFO) method. Inventory consists primarily of finished goods. Shipping and handling costs are included in the cost of inventory. In assessing the inventory value, we make estimates and judgments regarding reserves required for product obsolescence, aging of inventory and other issues potentially affecting the saleable condition of products. In performing such evaluations, we utilize historical experience as well as current market information. The reserve for obsolescence was $296,820 and $0 as of June 30, 2014 and 2013, respectively. The addition to the reserve was $165,165 and $0 for the quarters ended June 30, 2014 and 2013, respectively.

Impairment of Long-Lived Assets – Our long-lived assets include property and equipment. We evaluate our long-lived assets for recoverability whenever events or changes in circumstances indicate that an asset may be impaired. In evaluating an asset for recoverability, we estimate the future cash flow expected to result from the use of the asset and eventual disposition. If the expected future undiscounted cash flow is less than the carrying amount of the asset, an impairment loss, equal to the excess of the carrying amount over the fair value of the asset, is recognized. We have determined there was no impairment charge during the quarters ended June 30, 2014 and 2013.

Income Taxes - As part of the process of preparing our consolidated financial statements, we are required to estimate our income tax provision (benefit) in each of the jurisdictions in which we operate. This process involves estimating our current income tax provision (benefit) together with assessing temporary differences resulting from differing treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included within our consolidated balance sheets. We regularly evaluate our ability to recover the reported amount of our deferred income taxes considering several factors, including our estimate of the likelihood of the Company generating sufficient taxable income in future years during the period over which the temporary differences reverse.

Recent Accounting Pronouncements

In April 2014, the Financial Accounting Standards Board ("FASB") issued an accounting standards update providing new guidance on the requirements for reporting a discontinued operation. The new guidance changes the criteria for reporting discontinued operations and enhances the reporting requirements for discontinued operations. Under the new guidance, a discontinued operation must represent a strategic shift that has or will have a major effect on an entity's operations and financial results. The revised standard will allow an entity to have certain continuing cash flows or involvement with the component after the disposal, and requires expanded disclosures. The standard is effective for reporting periods beginning after December 15, 2014. Management does not anticipate that the adoption of this standard will have a significant impact on the Company's consolidated financial statements.

In May 2014, the FASB issued a comprehensive new standard which amends revenue recognition principles and provides a single set of criteria for revenue recognition among all industries. The new standard provides a five step framework whereby revenue is recognized when promised goods or services are transferred to a customer at an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard also requires enhanced disclosures pertaining to revenue recognition in both interim and annual periods. The standard is effective for interim and annual periods beginning after December 15, 2016 and allows for adoption using a full retrospective method, or a modified retrospective method. Management has not yet assessed the method of adoption or the expected impact the new standard will have on the Company's consolidated financial statements.

- 17 -


The Company does not believe there are any other recent accounting pronouncements that would have a material impact on its financial position or results of operations.

Inflation

Inflationary factors such as increases in the cost of our sales and overhead costs may adversely affect our operating results. Although we do not believe that inflation has had a material impact on our financial position or results of operations to date, a high rate of inflation in the future may have an adverse effect on our ability to maintain current levels of gross margin and selling, general and administrative expenses as a percentage of net sales if the selling prices of our products do not increase with these increased costs.

Off-Balance Sheet Arrangements

As of June 30, 2014, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to its stockholders.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not Applicable.

ITEM 4. CONTROLS AND PROCEDURES.

Disclosure Controls and Procedures

As of June 30, 2014, the Company’s management, under the direction of its Chief Executive Officer and the Chief Financial Officer, Mr. Sean Macdonald, carried out an evaluation of the effectiveness of the design and operation of the disclosure controls and procedures pursuant to Exchange Act Rule 13a-15. Our disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed in our SEC reports is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms, and is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based upon that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer determined that the Company’s disclosure controls and procedures were deemed to be effective.

Changes in Internal Controls over Financial Reporting

There were no changes in our internal controls over financial reporting during the period ended June 30, 2014, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II
OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

From time to time, we may become involved in various lawsuits and legal proceedings in the ordinary course of our business. Other than as set forth below, we are currently not aware of any legal proceedings the ultimate outcome of which, in our judgment based on information currently available, would have a material adverse affect on our business, financial condition or operating results.

- 18 -


ITEM 1A. RISK FACTORS.

There are no material changes from the risk factors previously disclosed in Item 1A “Risk Factors” of our annual report on Form 10-K for the period ended December 31, 2013.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

None.

- 19 -


ITEM 5. OTHER INFORMATION.

We have no information to disclose that was required to be in a report on Form 8-K during the period covered by this report, but was not reported. There have been no material changes to the procedures by which security holders may recommend nominees to our board of directors.

ITEM 6. EXHIBITS.

The following exhibits are filed as part of this report or incorporated by reference:

Exhibit No.   Description
31.1  

Certifications of Principal Executive Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2  

Certifications of Principal Financial Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1  

Certifications of Principal Executive Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2  

Certifications of Principal Financial Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101*  

Interactive data files pursuant to Rule 405 of Regulation S-T


*

Filed with this Form 10-Q for Leatt Corporation. Pursuant to Rule 406T of Regulation S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or for purposes of Section 18 of the Securities Act of 1934, as amended, and otherwise are not subject to liability under those sections.

- 20 -


SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: August 14, 2014 LEATT CORPORATION
   
   
  By: /s/ Sean Macdonald
  Sean Macdonald
  Chief Executive Officer and Chief Financial Officer
  (Principal Executive, Financial and Accounting Officer)

- 21 -


EXHIBIT INDEX

Exhibit No.   Description
31.1  

Certifications of Principal Executive Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2  

Certifications of Principal Financial Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1  

Certifications of Principal Executive Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2  

Certifications of Principal Financial Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101*  

Interactive data files pursuant to Rule 405 of Regulation S-T


_____________
*

Filed with this Form 10-Q for Leatt Corporation. Pursuant to Rule 406T of Regulation S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or for purposes of Section 18 of the Securities Act of 1934, as amended, and otherwise are not subject to liability under those sections.